Naif Althonayan
Papers
1
Total Citations
3
H-Index
1
About
Dr. Naif Althonayan is a urologic oncologist whose research centers on optimizing surgical outcomes for renal cell carcinoma (RCC), with a particular focus on balancing oncological efficacy with renal function preservation. His most cited work, a 2023 comparative study on partial versus total nephrectomies in T3 stage RCC, addresses a critical controversy in urologic oncology—whether nephron-sparing surgery is feasible in locally advanced disease. By demonstrating that partial nephrectomy can preserve renal function without compromising cancer control in select T3a patients, Dr. Althonayan provides evidence that challenges traditional treatment paradigms and expands surgical options. Though his citation count is still building, this work has already garnered 3 citations, signaling growing recognition among peers. His contributions are particularly impactful for surgeons navigating the delicate trade-off between radical excision and quality of life. Dr. Althonayan’s research reflects a commitment to patient-centered, evidence-based urologic care, and his findings offer practical guidance for managing complex RCC cases. As his bibliography grows, he is poised to become a key voice in the evolving landscape of kidney cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1